Skip to main content
    S

    Spero Therapeutics Inc (SPRO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.95
    -0.05 (-5.35%)

    Market Cap: $58.26M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Spero Therapeutics Inc (SPRO) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Spero Therapeutics are Grace Therapeutics (GRCE), Mereo BioPharma Group PLC ADR (MREO) and Gain Therapeutics (GANX). By market cap, Spero Therapeutics ranks 5th of the 13 companies on this page; Pmv Pharmaceuticals (PMVP) is the largest at $95.93M.

    Peer Comparison

    SPRO's revenue growth of -95.6% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Spero Therapeutics (SPRO)$58.26M11.1x1.3x15.7%N/A-95.6%0.00%
    Grace Therapeutics, Inc. (GRCE)$38.08MN/AN/A0.0%N/A0.0%0.00%
    Mereo BioPharma Group PLC ADR (MREO)$49.11MN/A61.3x0.0%-116.6%0.0%0.00%
    Gain Therapeutics Inc (GANX)$46.31MN/AN/A0.0%-170.5%-100.0%0.00%
    Serina Therapeutics Inc (SER)$36.93MN/A288.7x0.0%-109.4%154.9%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    Heron Therapeuti (HRTX)$59.08MN/A0.4x-14.5%-8.4%-7.8%0.00%
    OS Therapies Incorporated (OSTX)$34.87MN/AN/A0.0%218.0%0.0%0.00%
    Neumora Therapeutics, Inc. (NMRA)$80.59MN/AN/A0.0%-260.5%0.0%0.00%
    Pliant Therapeutics Inc (PLRX)$43.21MN/AN/A0.0%N/A-100.0%0.00%
    Pmv Pharmaceuticals Inc (PMVP)$95.93MN/AN/A0.0%N/A0.0%0.00%
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)$36.15MN/AN/A0.0%N/A0.0%0.00%
    Verrica Pharmaceuticals Inc (VRCA)$61.16MN/A3.0x-189.2%-496.2%-51.8%0.00%
    Peer median$44.76MN/A3.0x0.0%-143.5%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Spero Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Grace Therapeutics, Inc. (GRCE)
    Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
    GRCE competitors
    Mereo BioPharma Group PLC ADR (MREO)
    Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops and markets therapeutic products for the treatment of oncology and rare diseases...
    MREO competitors
    Gain Therapeutics Inc (GANX)
    Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding.
    GANX competitors
    Serina Therapeutics Inc (SER)
    Serina Therapeutics Inc is a pioneering biotechnology company focused on developing innovative solutions for unmet medical needs in oncology and neurology...
    SER competitors
    Plus Therapeutics Inc (PSTV)
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    Heron Therapeuti (HRTX)
    Heron Therapeutics, Inc., a biotechnology company, is dedicated to developing treatments to address unmet medical needs.
    HRTX competitors
    OS Therapies Incorporated (OSTX)
    OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs...
    OSTX competitors
    Neumora Therapeutics, Inc. (NMRA)
    Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases...
    NMRA competitors
    Pliant Therapeutics Inc (PLRX)
    Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers, develops...
    PLRX competitors
    Pmv Pharmaceuticals Inc (PMVP)
    PMV Pharmaceuticals, Inc., a precision oncology company, is dedicated to the discovery and development of small molecule tumor agnostic therapies for p53...
    PMVP competitors
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)
    Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human...
    TELO competitors
    Verrica Pharmaceuticals Inc (VRCA)
    Verrica Pharmaceuticals Inc., a dermatological therapy company, develops and markets treatments for people with skin conditions in the United States.
    VRCA competitors

    Frequently Asked Questions About SPRO

    Who are Spero Therapeutics' main competitors?

    The companies most similar to Spero Therapeutics include Grace Therapeutics (GRCE), Mereo BioPharma Group PLC ADR (MREO), Gain Therapeutics (GANX), Serina Therapeutics (SER) and Plus Therapeutics (PSTV), listed from the closest match.

    Who is Spero Therapeutics' biggest competitor?

    Pmv Pharmaceuticals (PMVP) is the largest of the similar companies at $95.93M; Grace Therapeutics (GRCE) is the closest match by business profile, size, sector and industry.

    How does SPRO stock compare with its competitors?

    SPRO's P/S is 1.3x against a peer median of 3.0x; its net margin is 15.7% against a peer median of 0.0%.

    Which of Spero Therapeutics' competitors pays a higher dividend?

    Spero Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Spero Therapeutics bigger than its competitors?

    No. Spero Therapeutics is 5th by market cap among the 13 companies on this page; the largest is Pmv Pharmaceuticals (PMVP) at $95.93M.